SubsidieMeestersNovel microsensing platform for remote patient monitoring
The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.
Projectdetails
Introduction
We have developed and in-human validated a new generation of implantable microstimulators for neuroprosthetics, accomplishing very thin (< 1 mm) and flexible devices with an unprecedented level of miniaturization as they lack batteries and bulky components.
Technology Overview
Our microstimulators are powered by an external system using an innovative wireless power transfer method that uses the human body as an electrical conductor of innocuous high frequency currents.
Application in Biomedical Sensing
While developing the microstimulators, we realized that this technology could also be used to create minimally invasive implants capable of sensing relevant biomedical parameters for remote patient monitoring (RPM).
Potential Impact on RPM
Our technology has the potential to revolutionize RPM, as it allows for the combination of different sensing capabilities in a single device and the creation of a network of implants for multi-site sensing.
Focus on Chronic Heart Failure
After analyzing several opportunities, we decided to focus the applicability of our sensing platform on chronic heart failure (HF) monitoring.
Understanding Chronic Heart Failure
Chronic HF is a long-term, persistent condition in which the heart is not able to efficiently pump blood to the body, causing symptoms such as limited physical activity and swelling.
Consequences of Chronic HF
With time, the patient decompensates, leading to repeated costly hospitalizations with an annual cost of care of US$30,000 per patient in the US, and a 5-year mortality rate of 50%.
Emerging Clinical Reality
RPM using implanted sensors is an emerging clinical reality for HF patients, as it optimizes medical management and treatment, improving their quality of life and outcomes.
Project Objective
The objective of FORESEE is to bring the implantable microsensing platform for RPM of HF patients from TRL3 up to completion of TRL5, and to develop a successful business strategy to ensure its future market access.
Target Patient Population
This initiative aims to benefit almost 10.5 million HF patients in the EU and US who are candidates for RPM.
Conclusion
The technological and business activities developed by our team, with strong scientific and business expertise, will ensure tech-to-market transition.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.051 |
| Totale projectbegroting | € 2.499.051 |
Tijdlijn
| Startdatum | 1-12-2023 |
| Einddatum | 30-11-2026 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- UNIVERSIDAD POMPEU FABRApenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Transition
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Very High Energy Electrons Beam for RadiotherapyeBeam4Therapy aims to revolutionize cancer treatment by developing compact, cost-effective VHEE radiotherapy using laser plasma accelerators to improve patient outcomes and reduce side effects. | EIC Transition | € 2.477.043 | 2022 | Details |
High-throughput hyperspectral imaging across the VIS-SWIR spectrum in a single deviceThe HYPERIA project aims to develop a novel hyperspectral imaging camera using Fourier Transform interferometry for enhanced sensitivity and wavelength range, targeting applications in food safety and waste separation. | EIC Transition | € 1.500.000 | 2022 | Details |
Therapeutic Antisense Oligonucleotides Targeting NUMB Alternative Splicing in Lung AdenocarcinomaThis project aims to develop Antisense Oligonucleotides to correct pathological splicing of the NUMB gene in lung adenocarcinomas, improving treatment efficacy and paving the way for clinical trials. | EIC Transition | € 2.899.553 | 2022 | Details |
Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platformNanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs. | EIC Transition | € 2.489.571 | 2022 | Details |
Very High Energy Electrons Beam for Radiotherapy
eBeam4Therapy aims to revolutionize cancer treatment by developing compact, cost-effective VHEE radiotherapy using laser plasma accelerators to improve patient outcomes and reduce side effects.
High-throughput hyperspectral imaging across the VIS-SWIR spectrum in a single device
The HYPERIA project aims to develop a novel hyperspectral imaging camera using Fourier Transform interferometry for enhanced sensitivity and wavelength range, targeting applications in food safety and waste separation.
Therapeutic Antisense Oligonucleotides Targeting NUMB Alternative Splicing in Lung Adenocarcinoma
This project aims to develop Antisense Oligonucleotides to correct pathological splicing of the NUMB gene in lung adenocarcinomas, improving treatment efficacy and paving the way for clinical trials.
Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platform
NanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoringThe 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery. | ERC STG | € 2.500.000 | 2022 | Details |
In-vessel implantable smart sensing device for personalised medicineThe IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations. | EIC Pathfinder | € 4.158.610 | 2023 | Details |
Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular DiseasesThe project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU. | EIC Pathfinder | € 3.979.006 | 2023 | Details |
Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoringThe Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations. | EIC Accelerator | € 2.299.633 | 2023 | Details |
Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoring
The 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery.
In-vessel implantable smart sensing device for personalised medicine
The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.
Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular Diseases
The project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU.
Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoring
The Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations.